Reuters reports the FDA’s Commissioner’s National Priority Voucher program has effectively been shelved after the program’s lack of new vouchers since former FDA Commissioner Marty Makary left. Sources cited by Reuters say applications remain open but are not advanced, as the executive council overseeing the reviews has gone dormant during leadership transition.